Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 5,600.00
+210.00 (3.90%)
At close: Jul 31, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 78.6 billion as of July 31, 2026. Its market cap has decreased by -22.87% in one year.
Market Cap
78.60B
Enterprise Value
152.76B
Revenue
205.39B
Ranking
n/a
PE Ratio
5.01
Stock Price
5,600.00
ChartMarket Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 78.60B, an increase of 503.11%. That is a compound annual growth rate of 7.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 78.60B | -14.76% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 96.90B |
| OPTUS Pharmaceutical | 96.35B |
| H.PIO | 87.82B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| KOREA PHARMA | 77.55B |
| Sam-A Pharm. | 74.52B |
| Hwail Pharmaceutical | 73.57B |
| Polaris AI Pharma | 68.41B |